Therapy‐related peripheral neuropathy in multiple myeloma patients
Marta Morawska(Lublin Oncology Center), Marek Hus(Medical University of Lublin), Norbert Grząśko(Lublin Oncology Center), Jolanta Wojciechowicz(1 Military Clinical Hospital with Outpatient Clinic), Magdalena Kostyra(1 Military Clinical Hospital with Outpatient Clinic)
Cited by 70
Related Papers
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2024|162
Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis
|Leukemia|2022|63